NCT00968981 2017-07-11A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy ExistsGenentech, Inc.Phase 1 Completed67 enrolled 18 charts